Lynn Malec - Concepedia

Author

Lynn Malec

Also Known As

Deanna Maida, Julie Rotival, L Malec, L. M. Malec, L. Malec, Loan MALEC, Loan Malec, Lynn M Malec, Lynn M. Malec, Lynn Malec

Publications

621

Citations

H-Index

Concepts

All Affiliations

Versiti Blood Center of Wisconsin Hemophilia Center of Western Pennsylvania Medical College of Wisconsin Children's Hospital of Pittsburgh University of Pittsburgh

About

Lynn Malec is an author at Versiti Blood Center of Wisconsin specializing in hematology, thrombosis, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	106
2	Health Sciences	3	3	46
3	Public Health	1	1	26
4	Allergy	1	1	17
5	Clinical Immunology	1	1	17

Lynn Malec

Publications

287

Citations

H-Index

Page 1

	Year	Citations
Venous thromboembolism in pediatric trauma patients: Ten‐year experience and long‐term follow‐up in a tertiary care center Christine M. Leeper, Madhav Vissa, James Cooper, Pediatric Blood & Cancer	2017	47
Regional variation and cost implications of prescribed extended half‐life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophilia Stacy E. Croteau, Dunlei Cheng, Alice J. Cohen, Haemophilia	2019	43
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial Margaret V. Ragni, Scott D. Rothenberger, Robert Feldman, The Lancet Haematology ThrombosisHematologyGynecologyHemostasisCoagulopathy	2023	34
The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United States Lynn Malec, Dunlei Cheng, Char Witmer, American Journal of Hematology	2020	31
Spontaneous bleeding and poor bleeding response with extended half‐life factor IX products: A survey of select US haemophilia treatment centres Lynn Malec, Stacy E. Croteau, Michael U. Callaghan, Haemophilia ThrombosisLaboratory HematologyBlood TransfusionClinical EpidemiologyHematology	2020	26
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A Lynn Malec, Flora Peyvandi, Anthony K.C. Chan, New England Journal of Medicine	2024	25
Design of the INHIBIT trial: preventing inhibitors by avoiding ‘danger’, prolonging half-life and promoting tolerance Margaret V. Ragni, Lynn Malec Expert Review of Hematology Inhibit TrialPromoting ToleranceImmunologyPathologyPharmacotherapy	2014	19
Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study Lynn Malec, An Van Damme, Anthony K.C. Chan, Blood Clinical ImmunologyImmunologyImmune RegulationPathologyImmune System	2023	17
Validation Study of the Composite Score to Identify Von Willebrand Disease in Children Lynn Malec, Charity G. Moore, Carolyn M. Bennett, Journal of Pediatric Hematology/Oncology	2015	13
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding Margaret V. Ragni, Guy Young, Glaivy Batsuli, Expert Review of Hematology	2023	12

Page 1